Integrative epigenomics in Sjögren´s syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signature.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
02 12 2021
Historique:
received: 13 01 2021
accepted: 19 10 2021
entrez: 3 12 2021
pubmed: 4 12 2021
medline: 28 1 2022
Statut: epublish

Résumé

Primary Sjögren's syndrome (SS) is a systemic autoimmune disease characterized by lymphocytic infiltration and damage of exocrine salivary and lacrimal glands. The etiology of SS is complex with environmental triggers and genetic factors involved. By conducting an integrated multi-omics study, we confirmed a vast coordinated hypomethylation and overexpression effects in IFN-related genes, what is known as the IFN signature. Stratified and conditional analyses suggest a strong interaction between SS-associated HLA genetic variation and the presence of Anti-Ro/SSA autoantibodies in driving the IFN epigenetic signature and determining SS. We report a novel epigenetic signature characterized by increased DNA methylation levels in a large number of genes enriched in pathways such as collagen metabolism and extracellular matrix organization. We identified potential new genetic variants associated with SS that might mediate their risk by altering DNA methylation or gene expression patterns, as well as disease-interacting genetic variants that exhibit regulatory function only in the SS population. Our study sheds new light on the interaction between genetics, autoantibody profiles, DNA methylation and gene expression in SS, and contributes to elucidate the genetic architecture of gene regulation in an autoimmune population.

Identifiants

pubmed: 34857786
doi: 10.1038/s41598-021-01324-0
pii: 10.1038/s41598-021-01324-0
pmc: PMC8640069
doi:

Substances chimiques

Autoantibodies 0
HLA Antigens 0
Interferons 9008-11-1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

23292

Investigateurs

Lorenzo Beretta (L)
Barbara Vigone (B)
Jacques-Olivier Pers (JO)
Alain Saraux (A)
Valérie Devauchelle-Pensec (V)
Divi Cornec (D)
Sandrine Jousse-Joulin (S)
Bernard Lauwerys (B)
Julie Ducreux (J)
Anne-Lise Maudoux (AL)
Carlos Vasconcelos (C)
Ana Tavares (A)
Esmeralda Neves (E)
Raquel Faria (R)
Mariana Brandão (M)
Ana Campar (A)
António Marinho (A)
Fátima Farinha (F)
Isabel Almeida (I)
Miguel Angel Gonzalez-Gay Mantecón (MAG)
Ricardo Blanco Alonso (RB)
Alfonso Corrales Martínez (AC)
Ricard Cervera (R)
Ignasi Rodríguez-Pintó (I)
Gerard Espinosa (G)
Rik Lories (R)
Ellen De Langhe (E)
Nicolas Hunzelmann (N)
Doreen Belz (D)
Torsten Witte (T)
Niklas Baerlecken (N)
Georg Stummvoll (G)
Michael Zauner (M)
Michaela Lehner (M)
Eduardo Collantes (E)
Rafaela Ortega-Castro (R)
Mª Angeles Aguirre-Zamorano (MA)
Alejandro Escudero-Contreras (A)
Mª Carmen Castro-Villegas (MC)
Norberto Ortego (N)
María Concepción Fernández Roldán (MCF)
Enrique Raya (E)
Inmaculada Jiménez Moleón (IJ)
Enrique de Ramon (E)
Isabel Díaz Quintero (ID)
Pier Luigi Meroni (PL)
Maria Gerosa (M)
Tommaso Schioppo (T)
Carolina Artusi (C)
Carlo Chizzolini (C)
Aleksandra Zuber (A)
Donatienne Wynar (D)
Laszló Kovács (L)
Attila Balog (A)
Magdolna Deák (M)
Márta Bocskai (M)
Sonja Dulic (S)
Gabriella Kádár (G)
Falk Hiepe (F)
Velia Gerl (V)
Silvia Thiel (S)
Manuel Rodriguez Maresca (MR)
Antonio López-Berrio (A)
Rocío Aguilar-Quesada (R)
Héctor Navarro-Linares (H)
Montserrat Alvarez (M)
Damiana Alvarez-Errico (D)
Nancy Azevedo (N)
Nuria Barbarroja (N)
Anne Buttgereit (A)
Qingyu Cheng (Q)
Carlo Chizzolini (C)
Jonathan Cremer (J)
Aurélie De Groof (A)
Ellen De Langhe (E)
Julie Ducreux (J)
Aleksandra Dufour (A)
Velia Gerl (V)
Maria Hernandez-Fuentes (M)
Laleh Khodadadi (L)
Katja Kniesch (K)
Tianlu Li (T)
Chary Lopez-Pedrera (C)
Zuzanna Makowska (Z)
Concepción Marañón (C)
Brian Muchmore (B)
Esmeralda Neves (E)
Bénédicte Rouvière (B)
Quentin Simon (Q)
Elena Trombetta (E)
Nieves Varela (N)
Torsten Witte (T)

Informations de copyright

© 2021. The Author(s).

Références

J Leukoc Biol. 2008 May;83(5):1194-200
pubmed: 18285404
J Autoimmun. 2012 Aug;39(1-2):57-63
pubmed: 22289719
Nucleic Acids Res. 2011 Jan;39(Database issue):D712-7
pubmed: 21071422
Arthritis Rheumatol. 2021 Jun;73(6):1073-1085
pubmed: 33497037
Clin Exp Rheumatol. 2018 May-Jun;36 Suppl 112(3):102-112
pubmed: 30156539
Diabetes Obes Metab. 2009 Feb;11 Suppl 1:2-7
pubmed: 19143809
Scand J Immunol. 2004 Jun;59(6):592-9
pubmed: 15182255
Nat Commun. 2019 Jun 13;10(1):2581
pubmed: 31197173
Bioinformatics. 2019 Sep 15;35(18):3257-3262
pubmed: 30753302
Bioessays. 2018 Feb;40(2):
pubmed: 29251357
Nature. 2012 Nov 1;491(7422):56-65
pubmed: 23128226
Ann Rheum Dis. 2017 Mar;76(3):625-628
pubmed: 28093418
Nat Genet. 2016 Oct;48(10):1279-83
pubmed: 27548312
Nat Commun. 2017 Aug 16;8(1):266
pubmed: 28814792
Best Pract Res Clin Rheumatol. 2016 Feb;30(1):189-220
pubmed: 27421224
Curr Opin Rheumatol. 2016 Sep;28(5):506-14
pubmed: 27227345
Matrix Biol. 2008 Jan;27(1):53-66
pubmed: 17689946
Epigenomics. 2016 Jan;8(1):105-17
pubmed: 26678685
Nat Genet. 2013 Oct;45(10):1238-1243
pubmed: 24013639
Bioinformatics. 2008 Jul 1;24(13):i390-8
pubmed: 18586739
Front Immunol. 2013 Jul 05;4:142
pubmed: 23847613
Rheumatology (Oxford). 2021 Feb 1;60(2):837-848
pubmed: 32889544
Arthritis Rheum. 2009 Apr;60(4):1065-75
pubmed: 19333922
Nat Genet. 2016 Oct;48(10):1284-1287
pubmed: 27571263
Arthritis Rheum. 2008 Feb;58(2):541-6
pubmed: 18240214
Bioinformatics. 2012 May 15;28(10):1353-8
pubmed: 22492648
Genome Biol. 2014;15(12):550
pubmed: 25516281
PLoS One. 2012;7(7):e41255
pubmed: 22829933
Nat Rev Immunol. 2012 Jan 06;12(2):125-35
pubmed: 22222875
Nat Genet. 2017 Jan;49(1):131-138
pubmed: 27918535
Nat Commun. 2016 Nov 29;7:13555
pubmed: 27898055
Ann Rheum Dis. 2016 Nov;75(11):2029-2036
pubmed: 26857698
Nat Rev Drug Discov. 2015 Feb;14(2):75-6
pubmed: 25633780
Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2770-5
pubmed: 16477017
Front Immunol. 2019 Aug 07;10:1880
pubmed: 31440254
Sci Rep. 2017 Aug 4;7(1):7354
pubmed: 28779180
Arthritis Rheumatol. 2014 Mar;66(3):731-9
pubmed: 24574234
Br J Cancer. 2010 Mar 2;102(5):873-82
pubmed: 20160729
Clin Immunol. 2016 Apr;165:60-7
pubmed: 26995659
Nat Genet. 2013 Nov;45(11):1284-92
pubmed: 24097067
Genome Med. 2018 Sep 4;10(1):64
pubmed: 30176915
Hum Genet. 2012 Sep;131(9):1403-21
pubmed: 22610502
Nature. 2021 Mar;591(7848):92-98
pubmed: 33307546
Nature. 2017 Oct 11;550(7675):204-213
pubmed: 29022597
Ann Rheum Dis. 2016 May;75(5):933-40
pubmed: 26183421
BMC Bioinformatics. 2011 Aug 04;12:323
pubmed: 21816040
Innovation (N Y). 2021 Jul 01;2(3):100141
pubmed: 34557778
Nat Genet. 2006 May;38(5):550-5
pubmed: 16642019
Clin Immunol. 2020 Jan;210:108314
pubmed: 31765834
Nat Genet. 2017 Jan;49(1):139-145
pubmed: 27918533
PLoS One. 2013 Jun 06;8(6):e64683
pubmed: 23762245
Bioinformatics. 2018 Dec 1;34(23):3983-3989
pubmed: 29931280
Science. 2014 Mar 7;343(6175):1246949
pubmed: 24604202
Curr Opin Rheumatol. 2013 Jul;25(4):480-7
pubmed: 23719365
Clin Immunol. 2018 Nov;196:21-33
pubmed: 29605707
Lancet. 2005 Jul 23-29;366(9482):321-31
pubmed: 16039337
Nat Genet. 2007 Oct;39(10):1202-7
pubmed: 17873877
Nat Genet. 2021 Sep;53(9):1311-1321
pubmed: 34493871
Arthritis Rheum. 2003 Aug;48(8):2240-5
pubmed: 12905478
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Arthritis Rheumatol. 2016 Dec;68(12):2936-2944
pubmed: 27332624
Front Immunol. 2021 Jul 16;12:702037
pubmed: 34335613
Am J Hum Genet. 2012 Jul 13;91(1):122-38
pubmed: 22748210
Genome Biol. 2016 Apr 30;17:79
pubmed: 27140173
Ann Rheum Dis. 2018 May;77(5):736-743
pubmed: 29437559
Autoimmun Rev. 2016 Nov;15(11):1038-1045
pubmed: 27490203
Front Immunol. 2013 Sep 20;4:290
pubmed: 24062752
Genes Immun. 2009 Jun;10(4):285-96
pubmed: 19404300
Am J Hum Genet. 2007 Sep;81(3):559-75
pubmed: 17701901
Ann Rheum Dis. 2002 Jun;61(6):554-8
pubmed: 12006334
Arthritis Rheum. 2005 Apr;52(4):1185-95
pubmed: 15818675
Nat Genet. 2006 Oct;38(10):1166-72
pubmed: 16998491
Nat Genet. 2006 Aug;38(8):904-9
pubmed: 16862161
Nature. 2007 May 24;447(7143):396-8
pubmed: 17522671
Arthritis Rheumatol. 2021 Jul;73(7):1288-1300
pubmed: 33455083
Autoimmun Rev. 2014 Jul;13(7):756-61
pubmed: 24657515
Genome Res. 2009 Sep;19(9):1655-64
pubmed: 19648217
Nature. 2009 Oct 8;461(7265):747-53
pubmed: 19812666
PLoS Genet. 2015 May 08;11(5):e1005223
pubmed: 25955312
Nat Biotechnol. 2013 Feb;31(2):142-7
pubmed: 23334450
Front Immunol. 2019 Jul 30;10:1686
pubmed: 31428085
Nat Genet. 2012 Mar 25;44(5):502-10
pubmed: 22446964
Arthritis Rheum. 2010 Aug;62(8):2262-71
pubmed: 20506202
Hum Mol Genet. 2017 Mar 1;26(5):1003-1017
pubmed: 28062664

Auteurs

María Teruel (M)

GENYO, Center for Genomics and Oncological Research Pfizer/University of Granada/Andalusian Regional Government, 18016, Granada, Spain.

Guillermo Barturen (G)

GENYO, Center for Genomics and Oncological Research Pfizer/University of Granada/Andalusian Regional Government, 18016, Granada, Spain.

Manuel Martínez-Bueno (M)

GENYO, Center for Genomics and Oncological Research Pfizer/University of Granada/Andalusian Regional Government, 18016, Granada, Spain.

Olivia Castellini-Pérez (O)

GENYO, Center for Genomics and Oncological Research Pfizer/University of Granada/Andalusian Regional Government, 18016, Granada, Spain.

Miguel Barroso-Gil (M)

GENYO, Center for Genomics and Oncological Research Pfizer/University of Granada/Andalusian Regional Government, 18016, Granada, Spain.

Elena Povedano (E)

GENYO, Center for Genomics and Oncological Research Pfizer/University of Granada/Andalusian Regional Government, 18016, Granada, Spain.

Martin Kerick (M)

IPBLN-CSIC, Instituto de Parasitología y Biomedicina López-Neyra, Consejo Superior de Investigaciones Científicas, 18016, Granada, Spain.

Francesc Català-Moll (F)

Epigenetics and Immune Disease Group, Josep Carreras Research Institute (IJC), 08916, Badalona, Barcelona, Spain.
IDIBELL, Bellvitge Biomedical Research Institute 08907 L'Hospitalet de Llobregat, Barcelona, Spain.

Zuzanna Makowska (Z)

Pharmaceuticals Division, Bayer Pharma Aktiengesellschaft, Berlin, Germany.

Anne Buttgereit (A)

Pharmaceuticals Division, Bayer Pharma Aktiengesellschaft, Berlin, Germany.

Jacques-Olivier Pers (JO)

Université de Brest, INSERM, Labex IGO, CHU de Brest, Brest, France.

Concepción Marañón (C)

GENYO, Center for Genomics and Oncological Research Pfizer/University of Granada/Andalusian Regional Government, 18016, Granada, Spain.

Esteban Ballestar (E)

Epigenetics and Immune Disease Group, Josep Carreras Research Institute (IJC), 08916, Badalona, Barcelona, Spain.
IDIBELL, Bellvitge Biomedical Research Institute 08907 L'Hospitalet de Llobregat, Barcelona, Spain.

Javier Martin (J)

IPBLN-CSIC, Instituto de Parasitología y Biomedicina López-Neyra, Consejo Superior de Investigaciones Científicas, 18016, Granada, Spain.

Elena Carnero-Montoro (E)

GENYO, Center for Genomics and Oncological Research Pfizer/University of Granada/Andalusian Regional Government, 18016, Granada, Spain. elena.carnero@genyo.es.

Marta E Alarcón-Riquelme (ME)

GENYO, Center for Genomics and Oncological Research Pfizer/University of Granada/Andalusian Regional Government, 18016, Granada, Spain. marta.alarcon@genyo.es.
Institute for Environmental Medicine, Karolinska Institutet, 171 67, Solna, Sweden. marta.alarcon@genyo.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH